REM-i Platform for Cell & Gene Therapy QC

About Deepcell

Deepcell is a private, venture-backed biotech company pioneering the field of 'morpholomics'—using AI to analyze and sort living cells based on their visual appearance. Its core product, the REM-i platform, integrates custom microfluidics, high-resolution imaging, and a self-supervised AI foundation model to provide a non-destructive, label-free workflow for single-cell analysis and enrichment. The company is targeting the research tools and diagnostics markets, with strategic partnerships in place, and appears to be in an early revenue stage as it commercializes its platform for academic and biopharma applications.

Therapeutic Areas